1. Home
  2. AAPG vs IOSP Comparison

AAPG vs IOSP Comparison

Compare AAPG & IOSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • IOSP
  • Stock Information
  • Founded
  • AAPG 2009
  • IOSP 1938
  • Country
  • AAPG China
  • IOSP United States
  • Employees
  • AAPG N/A
  • IOSP N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • IOSP Major Chemicals
  • Sector
  • AAPG Health Care
  • IOSP Industrials
  • Exchange
  • AAPG Nasdaq
  • IOSP Nasdaq
  • Market Cap
  • AAPG 2.2B
  • IOSP 2.2B
  • IPO Year
  • AAPG 2025
  • IOSP 1998
  • Fundamental
  • Price
  • AAPG $24.40
  • IOSP $85.08
  • Analyst Decision
  • AAPG Buy
  • IOSP Strong Buy
  • Analyst Count
  • AAPG 1
  • IOSP 1
  • Target Price
  • AAPG N/A
  • IOSP $155.00
  • AVG Volume (30 Days)
  • AAPG 14.1K
  • IOSP 171.0K
  • Earning Date
  • AAPG 06-10-2025
  • IOSP 05-08-2025
  • Dividend Yield
  • AAPG N/A
  • IOSP 1.92%
  • EPS Growth
  • AAPG N/A
  • IOSP N/A
  • EPS
  • AAPG N/A
  • IOSP 1.08
  • Revenue
  • AAPG $134,352,180.00
  • IOSP $1,786,000,000.00
  • Revenue This Year
  • AAPG N/A
  • IOSP $0.74
  • Revenue Next Year
  • AAPG $389.09
  • IOSP $7.75
  • P/E Ratio
  • AAPG N/A
  • IOSP $78.62
  • Revenue Growth
  • AAPG 341.77
  • IOSP N/A
  • 52 Week Low
  • AAPG $16.50
  • IOSP $80.32
  • 52 Week High
  • AAPG $26.55
  • IOSP $133.53
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • IOSP 37.91
  • Support Level
  • AAPG N/A
  • IOSP $84.46
  • Resistance Level
  • AAPG N/A
  • IOSP $87.94
  • Average True Range (ATR)
  • AAPG 0.00
  • IOSP 2.48
  • MACD
  • AAPG 0.00
  • IOSP -0.28
  • Stochastic Oscillator
  • AAPG 0.00
  • IOSP 5.59

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About IOSP Innospec Inc.

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Fuel Specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field service providers in the extraction of oil and gas. The Performance Chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.

Share on Social Networks: